GLI -MF TRIO Manufacturers Suppliers - Third Party Manufacturing - For PCD Franchise
GLIMEPIRIDE 1MG+ METFORMIN 500MG + VOGLIBOSE 0.2 MG
GLI-MF TRIO is a highly effective combination tablet for the treatment of Type 2 Diabetes Mellitus, combining Glimepiride, Metformin, and Voglibose. This triple therapy improves glycemic control by targeting different aspects of blood sugar regulation—insulin secretion, insulin sensitivity, and glucose absorption from the intestine.
Glimepiride (a sulfonylurea) stimulates the pancreas to produce more insulin.
Metformin (a biguanide) reduces glucose production in the liver and improves insulin sensitivity.
Voglibose (an alpha-glucosidase inhibitor) slows carbohydrate digestion to reduce post-meal sugar spikes.
Manufactured in GMP and GLP-certified facilities, GLI-MF TRIO is available for third-party manufacturing and PCD pharma franchise with full monopoly rights and promotional support.
Management of Type 2 Diabetes Mellitus
Blood sugar control (fasting and postprandial)
Prevention of long-term diabetic complications
Ideal for patients not controlled on dual therapy
Take the tablet as prescribed by a healthcare provider.
Typically taken before meals to control postprandial sugar.
Swallow whole with water, do not crush or chew.
Regular glucose monitoring is advised.
Hypoglycemia (low blood sugar)
Nausea or vomiting
Diarrhea
Stomach discomfort
Flatulence
Dizziness
Inform the doctor of any kidney, liver, or heart condition.
Not suitable during pregnancy or breastfeeding without medical advice.
Avoid alcohol consumption during treatment.
Monitor sugar levels regularly to avoid hypoglycemia.
Q1: What is GLI-MF TRIO used for?
A: It is used to treat type 2 diabetes by controlling blood sugar levels through a triple-action mechanism.
Q2: Can GLI-MF TRIO be taken without food?
A: No, it should be taken before meals to prevent sugar spikes.
Q3: Is this medicine safe for long-term use?
A: Yes, when taken under medical supervision with regular glucose monitoring.
Q4: Is GLI-MF TRIO available for PCD franchise?
A: Yes, Algen Healthcare offers GLI-MF TRIO for PCD pharma franchise and third-party manufacturing.
Contact Algen Healthcare –
Name: Algen Healthcare
Phone: +91 9868265827 +91 9319088494
Email at: sales@algenhealthcare.co, marketingalgen1@gmail.com, salesalgenhealthcare@gmail.com
Plot No: 456, First Floor, Industrial Area, Phase: 1, Panchkula Haryana (134113)
Work Office: 134/2, Mouza-Ogli, Village-Kheri, Tehsil-Nahan, Kala-Amb, Distt.- Sirmour (H.P.) (173030)
packsize | 10*10 |
---|---|
packstyle | BLISTER |